Vyriad
During Harry Hoffman’s 25 years of service as Mayo’s Chief Investment Officer and Treasurer which ended December 2020, Mayo Clinic achieved top decile investment performance among a universe of major tax-exempt institutions and grew its investment assets by over ten-fold. Outside of Mayo, Harry has served on the boards of several large family offices and is a former trustee of the Endowment Board of the American Red Cross, The Investment Fund for Foundations (TIFF) and the Ronald McDonald House of Rochester. He is also a founding member and vice chair of the Southeast Minnesota Capital Fund. Harry earned his B.A. degree from University of Minnesota and his M.B.A. from Yale School of Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Vyriad
Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.